The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.06 in the prior trading day, Opus Genetics Inc (NASDAQ: IRD) closed at $0.91, down -14.05%. In other words, the price has decreased by -$14.05 from its previous closing price. On the day, 0.6 million shares were traded. IRD stock price reached its highest trading level at $1.0698 during the session, while it also had its lowest trading level at $0.878.
Ratios:
Our goal is to gain a better understanding of IRD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.63 and its Current Ratio is at 6.63. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 22 ’24 when Jayagopal Ashwath bought 3,500 shares for $1.76 per share. The transaction valued at 6,178 led to the insider holds 78,500 shares of the business.
Magrath George bought 5,000 shares of IRD for $8,772 on May 17 ’24. The Chief Executive Officer now owns 430,000 shares after completing the transaction at $1.75 per share. On Mar 21 ’24, another insider, SCHACHLE JOSEPH K, who serves as the Chief Operating Officer of the company, bought 2,000 shares for $2.05 each. As a result, the insider paid 4,100 and bolstered with 2,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRD now has a Market Capitalization of 28762060 and an Enterprise Value of -3172435. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.43 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at -0.379 whereas that against EBITDA is 0.108.
Stock Price History:
Over the past 52 weeks, IRD has reached a high of $3.40, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -26.86%, while the 200-Day Moving Average is calculated to be -46.12%.
Shares Statistics:
The stock has traded on average 130.98K shares per day over the past 3-months and 177220 shares per day over the last 10 days, according to various share statistics. A total of 31.57M shares are outstanding, with a floating share count of 26.07M. Insiders hold about 17.40% of the company’s shares, while institutions hold 7.94% stake in the company. Shares short for IRD as of 1730332800 were 937096 with a Short Ratio of 7.15, compared to 1726185600 on 1095057. Therefore, it implies a Short% of Shares Outstanding of 937096 and a Short% of Float of 3.11.
